All deaths (n=323) | All diagnoses (N=323) | AML (N=107) | DLBCL (N=102) | Myeloma (N=114) | |||||
---|---|---|---|---|---|---|---|---|---|
Place of death discussion | Place of death discussion | Place of death discussion | Place of death discussion | ||||||
Yes N (%) | No* N (%) | Yes N (%) | No* N (%) | Yes N (%) | No* N (%) | Yes N (%) | No* N (%) | ||
Total | 323 (100) | 142 (100) | 181 (100) | 49 (100) | 58 (100) | 43 (100) | 59 (100) | 50 (100) | 64 (100) |
Sex | |||||||||
Male | 178 (55.1) | 76 (53.5) | 102 (56.4) | 27 (55.1) | 34 (58.6) | 17 (39.5) | 29 (49.2) | 32 (64.0) | 39 (60.9) |
Female | 145 (44.9) | 66 (46.5) | 79 (43.6) | 22 (44.9) | 24 (41.4) | 26 (60.5) | 30 (50.8) | 18 (36.0) | 25 (39.1) |
Age at diagnosis | |||||||||
≤60 | 58 (17.9) | 25 (17.6) | 33 (18.2) | 9 (18.4) | 16 (27.6) | 9 (20.9) | 9 (15.2) | 7 (14.0) | 8 (12.5) |
61–74 | 122 (37.8) | 50 (35.2) | 72 (39.8) | 16 (32.6) | 23 (39.7) | 13 (30.2) | 26 (44.1) | 21 (42.0) | 23 (35.9) |
75+ | 143 (44.3) | 67 (47.2) | 76 (42.0) | 24 (49.0) | 19 (32.8) | 21 (48.8) | 24 (40.7) | 22 (44.0) | 33 (51.6) |
Mean (SD) | 71.5 (12.8) | 71.9 (12.6) | 71.2 (13.0) | 71.7 (13.9) | 66.5 (14.4) | 71.3 (13.5) | 73.0 (13.3) | 72.5 (10.4) | 73.9 (10.1) |
Age at death | |||||||||
≤60 | 53 (16.4) | 23 (16.2) | 30 (16.6) | 8 (16.3) | 16 (27.6) | 8 (18.6) | 8 (13.5) | 7 (14.0) | 6 (9.4) |
61–74 | 117 (36.2) | 49 (34.5) | 68 (37.6) | 16 (32.7) | 22 (37.9) | 14 (32.6) | 25 (42.4) | 19 (14.0) | 21 (32.8) |
75+ | 153 (47.4) | 70 (49.3) | 83 (45.8) | 25 (51.0) | 20 (34.5) | 21 (48.8) | 26 (44.1) | 24 (48.0) | 37 (57.8) |
Mean (SD) | 72.4 (12.7) | 72.8 (12.3) | 72.0 (13.0) | 72.2 (13.8) | 67.2 (14.2) | 72.2 (13.3) | 73.6 (13.4) | 73.9 (10.0) | 75.0 (10.0) |
Time from diagnosis to death (months) | |||||||||
≤1 | 75 (23.2) | 21 (14.8) | 54 (29.8) | 10 (20.4) | 20 (34.4) | 9 (20.9) | 23 (39.0) | 2 (4.0) | 11 (17.2) |
1–6 | 83 (25.7) | 35 (24.7) | 48 (26.5) | 19 (38.8) | 16 (27.6) | 9 (20.9) | 18 (30.5) | 7 (14.0) | 14 (21.9) |
6–12 | 62 (19.2) | 33 (23.2) | 29 (16.1) | 13 (26.5) | 11 (19.0) | 11 (25.6) | 5 (8.5) | 9 (18.0) | 13 (20.3) |
12+ | 103 (31.9) | 53 (37.3) | 50 (27.6) | 7 (14.3) | 11 (19.0) | 14 (32.6) | 13 (22.0) | 32 (64.0) | 26 (40.6) |
Mean (SD) | 10.6 (12.0) | 11.8 (11.6) | 9.7 (12.2) | 5.9 (6.1) | 7.4 (9.8) | 10.6 (11.2) | 7.7 (12.1) | 18.6 (12.6) | 13.5 (13.5) |
Place of death | |||||||||
Hospital | 240 (74.3) | 88 (62.0) | 152 (84.0) | 28 (57.1) | 53 (91.4) | 28 (65.1) | 50 (84.7) | 32 (64.0) | 49 (76.6) |
Home | 49 (15.2) | 34 (23.9) | 15 (8.3) | 13 (26.5) | 3 (5.2) | 10 (23.3) | 5 (8.5) | 11 (22.0) | 7 (10.9) |
Hospice | 18 (5.6) | 13 (9.2) | 5 (2.8) | 6 (12.3) | 1 (1.7) | 4 (9.3) | 2 (3.4) | 3 (6.0) | 2 (3.1) |
Nursing home | 16 (4.9) | 7 (4.9) | 9 (4.9) | 2 (4.1) | 1 (1.7) | 1 (2.3) | 2 (3.4) | 4 (8.0) | 6 (9.4) |
*No evidence of a discussion about preferred place of death could be found in medical records.
AML, acute myeloid leukaemia; DLBCL, diffuse large B-cell lymphoma; HMRN, Haematological Malignancy Research Network.